

Related Companies | [] | ||||||||
Related Funds | [] | ||||||||
English | |||||||||
oda_WinningATenderAbstract| |
| ||||||||
oda_UpdateAnnouncementFlag| |
| Hayır (No) | |||||||
oda_CorrectionAnnouncementFlag| |
| Hayır (No) | |||||||
oda_DateOfThePreviousNotificationAboutTheSameSubject| |
| - | |||||||
oda_DelayedAnnouncementFlag| |
| Hayır (No) | |||||||
oda_AnnouncementContentSection| |
| ||||||||
oda_SubjectOfTender| |
| Chemotherapy Drug Preparation and Administration Services Procurement | |||||||
oda_PartyOpenedTender| |
| Bezmialem Vakıf University Health Practice and Research Center | |||||||
oda_BoardDecisionOnBidForTender| |
| - | |||||||
oda_OtherPartiesIfParticipatedInTheTenderAsAGroup| |
| - | |||||||
oda_ShareOfTheCompanyIfParticipatedInTheTenderAsAGroup| |
| - | |||||||
oda_DateOfTenderBid| |
| 28/08/2026 | |||||||
oda_EndingUpDateOfTheTender| |
| - | |||||||
oda_TenderResult| |
| The tender has been awarded to our Company. | |||||||
oda_TenderValue| |
| 35.225.854,40 | |||||||
oda_ShareOfCompanyInTenderValue| |
| - | |||||||
oda_RatioOfTenderValueCorporateShareAmountToGrossSalesRevenueOnPubliclyDisclosedTheLatestFinancialStatementOfCompany| |
| - | |||||||
oda_ExplanationSection| |
| ||||||||
oda_ExplanationTextBlock| | Our Company participated in the "3-Year Chemotherapy Drug Preparation and Administration Services Procurement" tender held by Bezmialem Vakıf University Health Practice and Research Center on 28 August 2026. Regarding the tender with Tender Registration Number (TRN) BVU2026022, the bid submitted by our Company in the amount of TRY 35,225,854.40 was determined by the tender commission to be the most economically advantageous bid. The finalized tender decision issued by the tender commission has been officially notified to our Company. Respectfully announced to the public. The English translation of this disclosure is attached hereto. In the event of any discrepancy between the disclosure texts, the Turkish version shall prevail. | ||||||||
We proclaim that our above disclosure is in conformity with the principles set down in “Material Events Communiqué” of Capital Markets Board, and it fully reflects all information coming to our knowledge on the subject matter thereof, and it is in conformity with our books, records and documents, and all reasonable efforts have been shown by our Company in order to obtain all information fully and accurately about the subject matter thereof, and we’re personally liable for the disclosures.